🇺🇸 FDA
Patent

US 7723311

Delivery of bioactive substances to target cells

granted A61KA61K41/00A61K9/0009

Quick answer

US patent 7723311 (Delivery of bioactive substances to target cells) held by United States of America as represented by the Secretary of the Air Force expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K41/00, A61K9/0009, A61K9/0019, A61K9/5094